We are live on ! Find out more
FMS icon

Fresenius Medical Care

189 hedge funds and large institutions have $770M invested in Fresenius Medical Care in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 63 increasing their positions, 43 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 14

117% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $602K

47% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 43

13% more funds holding

Funds holding: 167189 (+22)

8% more capital invested

Capital invested by funds: $713M → $770M (+$56.9M)

0.19% more ownership

Funds ownership: 11.41%11.59% (+0.19%)

Holders
189
Holders Change
+22
Holders Change %
+13.17%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
38
Increased
63
Reduced
43
Closed
14
Calls
$1.31M
Puts
$602K
Net Calls
+$704K
Net Calls Change
+$344K
Name Holding Trade Value Shares
Change
Change in
Stake
CGH
26
Crossmark Global Holdings
Texas
$1.46M +$30.3K +1,398 +2%
Optiver Holding
27
Optiver Holding
Netherlands
$1.37M +$978K +45,045 +295%
Pathstone Holdings
28
Pathstone Holdings
New Jersey
$1.35M +$510K +23,489 +65%
DC
29
Davenport & Co
Virginia
$1.32M +$18.7K +862 +2%
UBS Group
30
UBS Group
Switzerland
$1.26M +$274K +12,640 +29%
Creative Planning
31
Creative Planning
Kansas
$1.21M +$332K +15,300 +40%
Mariner
32
Mariner
Kansas
$1.19M +$258K +11,871 +29%
Bank of America
33
Bank of America
North Carolina
$1.12M -$210K -9,678 -16%
EI
34
Ethic Inc
New York
$1.12M +$214K +9,856 +25%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$1.1M -$247K -11,400 -19%
MCM
36
Mork Capital Management
California
$1.07M
SA
37
Sanctuary Advisors
Indiana
$983K +$856K +39,434 New
HCMT
38
Highland Capital Management (Tennessee)
Tennessee
$976K -$23.9K -1,100 -2%
UCI
39
Uncommon Cents Investing
Wisconsin
$920K -$16.4K -755 -2%
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$850K +$815K +37,539 New
VC
41
Veracity Capital
Georgia
$842K -$314K -14,467 -28%
OSAM
42
O'Shaughnessy Asset Management
Connecticut
$762K -$60.8K -2,800 -8%
VPIM
43
Vanguard Personalized Indexing Management
California
$759K +$135K +6,232 +23%
Wells Fargo
44
Wells Fargo
California
$732K -$3.82K -176 -0.5%
LWAM
45
Legacy Wealth Asset Management
Minnesota
$731K -$13.3K -612 -2%
Cerity Partners
46
Cerity Partners
New York
$725K +$127K +5,853 +22%
SFM
47
Signet Financial Management
New Jersey
$716K -$78K -3,595 -10%
Charles Schwab
48
Charles Schwab
California
$704K +$193K +8,913 +40%
National Bank of Canada
49
National Bank of Canada
Quebec, Canada
$674K +$141K +6,486 +28%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$649K -$279K -12,871 -31%

FMS Hedge Fund Activity: Q4 2024 in Review

189 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2024, worth a combined $770M — up 8% from $713M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new FMS positions and 14 closed out — a net gain of 24 holders — while 63 added to existing stakes and 43 trimmed.

The largest buyer was Millennium Management, adding an estimated $15.4M. The largest seller was Pzena Investment Management, cutting an estimated $20.2M.

  • 189 institutional investors held Fresenius Medical Care (FMS) as of Q4 2024, up from 167 in Q3 2024.
  • Funds reported $770M of Fresenius Medical Care stock for Q4 2024, up 8% quarter-over-quarter.
  • 38 funds opened new Fresenius Medical Care positions in Q4 2024 and 14 closed out, a net change of +24 holders.
  • The largest Fresenius Medical Care buyer in Q4 2024 was Millennium Management, an estimated $15.4M added.
  • The largest Fresenius Medical Care seller in Q4 2024 was Pzena Investment Management, an estimated $20.2M sold.

Based on aggregated 13F filings for Q4 2024.